These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 14614615)
1. Biclonal multiple myeloma in liver cirrhosis due to hepatitis C virus infection. Tashiro M; Tabaru A; Narita R; Sugihara Y; Otsuki M J Gastroenterol; 2003; 38(10):1017-8. PubMed ID: 14614615 [No Abstract] [Full Text] [Related]
2. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma. Leone N; Rizzetto M Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection and new association with extrahepatic disease: multiple myeloma. Montella M; Crispo A; Russo F; Ronga D; Tridente V; Tamburini M Haematologica; 2000 Aug; 85(8):883-4. PubMed ID: 10942947 [No Abstract] [Full Text] [Related]
4. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C. Sanyal AJ; Banas C; Sargeant C; Luketic VA; Sterling RK; Stravitz RT; Shiffman ML; Heuman D; Coterrell A; Fisher RA; Contos MJ; Mills AS Hepatology; 2006 Apr; 43(4):682-9. PubMed ID: 16502396 [TBL] [Abstract][Full Text] [Related]
5. [Clinical features and prognosis of decompensated hepatitis C virus related cirrhosis]. Wu CH; Tian GS; Wang QH; Yu YY; Dou YQ; Xu XY Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):516-9. PubMed ID: 18649764 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study. Vaiphei K; Pal NS; Arora SK Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884 [TBL] [Abstract][Full Text] [Related]
7. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases. Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480 [TBL] [Abstract][Full Text] [Related]
8. Management of HCV-related end-stage liver disease in HIV-coinfected patients. Merchante N; Jiménez-Saenz M; Pineda JA AIDS Rev; 2007; 9(3):131-9. PubMed ID: 17982938 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma. Rodríguez-García A; Linares M; Morales ML; Allain-Maillet S; Mennesson N; Sanchez R; Alonso R; Leivas A; Pérez-Rivilla A; Bigot-Corbel E; Hermouet S; Martínez-López J Front Immunol; 2021; 12():797209. PubMed ID: 35087522 [TBL] [Abstract][Full Text] [Related]
10. [The development of multiple myeloma in chronic diffuse liver diseases with a long course of monoclonal immunoglobulinopathy (a description of 2 cases)]. Krel' PE; Andreeva NE; Aprosina ZG Ter Arkh; 1991; 63(8):130-4. PubMed ID: 1792603 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing. Fattovich G; Llovet JM J Hepatol; 2006 Jun; 44(6):1013-6. PubMed ID: 16678654 [No Abstract] [Full Text] [Related]
12. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma. Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765 [TBL] [Abstract][Full Text] [Related]
13. Genetic-based Risk Assessment for Hepatocellular Carcinoma in Patients with Hepatitis C: Where Do We Stand? Choi J; Lim YS EBioMedicine; 2017 Feb; 15():6-7. PubMed ID: 27979732 [No Abstract] [Full Text] [Related]
14. Primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis. Hara T; Nishi S; Horimoto A; Takenaka S; Ibata Y; Akamatsu H J Gastroenterol Hepatol; 2001 Aug; 16(8):948-9. PubMed ID: 11555118 [No Abstract] [Full Text] [Related]
15. Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications. Pradat P; Tillmann HL; Sauleda S; Braconier JH; Saracco G; Thursz M; Goldin R; Winkler R; Alberti A; Esteban JI; Hadziyannis S; Rizzetto M; Thomas H; Manns MP; Trepo C; J Viral Hepat; 2007 Aug; 14(8):556-63. PubMed ID: 17650289 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal. Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971 [TBL] [Abstract][Full Text] [Related]
17. [Natural history of hepatitis C]. Wei L Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):102. PubMed ID: 14980113 [No Abstract] [Full Text] [Related]
18. [The role of the C virus in the chronicity of viral hepatitis]. Claici C; Nicoară E; Roşiu N; Strain R; Vâlculescu C; Chidiosan CM; Nicolescu I; Cioflec D; Claici D; Don E Bacteriol Virusol Parazitol Epidemiol; 1994; 39(1-2):70-2. PubMed ID: 7981531 [No Abstract] [Full Text] [Related]
19. Risk of hepatitis C virus infection, Waldenström's macroglobulinemia, and monoclonal gammopathies. Silvestri F; Barillari G; Fanin R; Zaja F; Infanti L; Patriarca F; Baccarani M; Pipan C; Falasca E; Botta GA Blood; 1996 Aug; 88(3):1125-6. PubMed ID: 8704227 [No Abstract] [Full Text] [Related]
20. The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosis. Viganò M; Aghemo A; Iavarone M Gastroenterology; 2007 Dec; 133(6):2076. PubMed ID: 18054591 [No Abstract] [Full Text] [Related] [Next] [New Search]